Amedisys Inc (AMED): Price and Financial Metrics

AMED POWR Grades

• Quality is the dimension where AMED ranks best; there it ranks ahead of 95.09% of US stocks.
• The strongest trend for AMED is in Momentum, which has been heading down over the past 161 days.
• AMED's current lowest rank is in the Momentum metric (where it is better than 5.64% of US stocks).

AMED Stock Summary

• AMEDISYS INC's stock had its IPO on September 2, 1994, making it an older stock than 77.69% of US equities in our set.
• Price to trailing twelve month operating cash flow for AMED is currently 22.74, higher than 79.18% of US stocks with positive operating cash flow.
• With a year-over-year growth in debt of -10.76%, AMEDISYS INC's debt growth rate surpasses just 24.59% of about US stocks.
• If you're looking for stocks that are quantitatively similar to AMEDISYS INC, a group of peers worth examining would be NHC, APEI, MTW, PRG, and CPHC.
• AMED's SEC filings can be seen here. And to visit AMEDISYS INC's official web site, go to www.amedisys.com.

AMED Valuation Summary

• AMED's price/sales ratio is 1.1; this is 50% lower than that of the median Healthcare stock.
• Over the past 243 months, AMED's price/sales ratio has gone up 0.7.

Below are key valuation metrics over time for AMED.

AMED Growth Metrics

The 2 year revenue growth rate now stands at 12.23%.
• The 4 year net cashflow from operations growth rate now stands at 143.77%.
• Its 5 year net income to common stockholders growth rate is now at 175.74%.

The table below shows AMED's growth in key financial areas (numbers in millions of US dollars).

AMED's Quality Factors

• AMED has a Quality Grade of A, ranking ahead of 99.52% of graded US stocks.
• AMED's asset turnover comes in at 1.321 -- ranking 11th of 81 Healthcare stocks.
• RDNT, CHE, and VCYT are the stocks whose asset turnover ratios are most correlated with AMED.

The table below shows AMED's key quality metrics over time.